Glycopyrrolate 0.2 MG/ML vial 20ML
Ended Awarded
- Contract number
- SPE2D325F323U
- Awardee
-
American Regent Inc. UEI RGVZVTHEDHT8
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,220
Award facts
- Contract value 100% obligated
- $1,220.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- East Yaphank, NY 11967, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense Medical Supply Chain awarded a $1,220 firm fixed-price delivery order to American Regent Inc. for the supply of Glycopyrrolate 0.2 mg/mL in 20 mL vials. The contract, awarded on August 15, 2025, with an ultimate completion date of August 20, 2025, represents a delivery order against an existing contract vehicle and carries no set-aside designation, indicating full and open competition. Performance will take place at American Regent's pharmaceutical manufacturing and distribution facility located in East Yaphank, New York. Glycopyrrolate is a critical anticholinergic medication commonly used in military medical treatment facilities for anesthesia support and other clinical applications.
American Regent Inc., a subsidiary of Daiichi Sankyo Group, is an established pharmaceutical manufacturer specializing in injectable drugs and sterile preparations for federal healthcare procurement. The company holds significant federal contract vehicles, including a $131.4 million multiple award Federal Supply Schedule contract with the Department of Veterans Affairs and a $13.8 million indefinite delivery/indefinite quantity contract with the Defense Logistics Agency Troop Support Medical. This delivery order aligns with American Regent's ongoing role as a primary supplier of essential injectable medications to support military medical readiness and federal healthcare systems, with the company consistently competing successfully for pharmaceutical supply contracts without set-aside protections.
Quick answers
Who was awarded contract SPE2D325F323U?
SPE2D325F323U was awarded to American Regent Inc. by Medical Supply Chain (Troop Support) on August 15, 2025.
How much is contract SPE2D325F323U worth?
The government has obligated $1,220 on SPE2D325F323U.
Is contract SPE2D325F323U an order under another contract?
Yes. SPE2D325F323U is a delivery order under SPE2D021D0008, an indefinite delivery contract.
Was contract SPE2D325F323U competed?
The extent of competition for SPE2D325F323U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award